Tracking over the time

Author

Metsera, a clinical-stage biotech company focusing on obesity treatment, has recently gone public and started to attract favorable analyst ratings from Wall Street firms, showcasing significant potential for share price growth.

Business & Finance Wall Street firms say this obesity beneficiary is a buy, with one calling for more than 85% upside
198 views
Happiness 😊